Global Market Reach Covis Pharma operates in 50+ countries, representing a vast market potential for international sales expansion.
Specialty Therapies Focus Specializing in life-threatening conditions and chronic illnesses, Covis Pharma offers unique therapeutic solutions that cater to niche markets with specific medical needs.
Private Equity Backing With Apollo Global Management as the private equity sponsor, Covis Pharma has financial backing that can support and drive sales growth initiatives at a global scale.
Tech-Driven Solutions Utilizing a tech stack that includes WordPress, jQuery, and HTTP/3, Covis Pharma demonstrates a commitment to leveraging technology to enhance sales and marketing strategies.
Revenue Potential Generating annual revenues between $50M - 100M, Covis Pharma presents significant sales opportunities for partnerships, collaborations, and product sales expansion.
5.5K
$1B
8.9K$1B
1.5K$100M$1B
15K$1B
989$10M
17K$1B
28K$1B
1K$1BCovis Pharma uses 8 technology products and services including Complianz, WordPress, jQuery, and more. Explore Covis Pharma's tech stack below.
| Covis Pharma Email Formats | Percentage |
| FLast@covispharma.com | 50% |
| FLast@covispharma.com | 50% |
Pharmaceutical ManufacturingZug, Switzerland501-1000 Employees
Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that improve our patients' lives. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.
Company Overview
Funding & FinancialsCovis Pharma's revenue is in the range of $50M$100M
Funding & FinancialsCovis Pharma's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com